UQ halted the development of the vaccine in response to false positives of HIV but CEPI said the molecular clamp technology remains a promising platform because it could enable rapid vaccine production against multiple viral pathogens. …
CEPI reinvests in UQ's second-generation molecular clamp vaccine platform
November 28, 2022 Latest NewsBioPharma
Latest Video
New Stories
-
An exchange that reveals the truth of a review that has now become a lot like 'Weekend at Bernie's'
June 3, 2026 - - Latest News -
Patient voices take centre stage at the 2026 Patient's Choice Awards
June 3, 2026 - - Latest News -
Officials confirm shift in Budget management of underspends
June 3, 2026 - - Latest News -
Invitation confusion clouds Delphi studies and captures medical device sector
June 3, 2026 - - Latest News -
Omico opens a new chapter in precision oncology research
June 1, 2026 - - Latest News -
Ex-MA executive named the first CEO of Medicinal Cannabis Council Australia
June 1, 2026 - - Latest News -
Oral RAS inhibitor doubles median survival and cuts death risk in metastatic pancreatic cancer
June 1, 2026 - - Latest News